Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1956 1
1960 1
1962 1
1963 9
1964 7
1965 7
1966 1
1969 3
1970 1
1971 4
1972 3
1973 4
1974 13
1975 28
1976 26
1977 42
1978 33
1979 31
1980 73
1981 103
1982 144
1983 162
1984 200
1985 224
1986 248
1987 217
1988 360
1989 453
1990 455
1991 513
1992 613
1993 621
1994 670
1995 784
1996 847
1997 866
1998 989
1999 1058
2000 1187
2001 1311
2002 1329
2003 1442
2004 1638
2005 1765
2006 1957
2007 2106
2008 2348
2009 2456
2010 2525
2011 2616
2012 2758
2013 2812
2014 3116
2015 3218
2016 3078
2017 3084
2018 3199
2019 3423
2020 3896
2021 3992
2022 3459
2023 3278
2024 1246

Text availability

Article attribute

Article type

Publication date

Search Results

65,482 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for tumor ag
Search for Tudor AG instead (2 results)
Polycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing.
Sadeghi HM, Adeli I, Calina D, Docea AO, Mousavi T, Daniali M, Nikfar S, Tsatsakis A, Abdollahi M. Sadeghi HM, et al. Int J Mol Sci. 2022 Jan 6;23(2):583. doi: 10.3390/ijms23020583. Int J Mol Sci. 2022. PMID: 35054768 Free PMC article. Review.
Medications, including 3-hydroxy-3-methyl-3-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors, thiazolidinediones, sodium-glucose cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors, glucose-like peptide-1 receptor agonists, mucolytic agents, and some supplement …
Medications, including 3-hydroxy-3-methyl-3-glutaryl-coenzyme A (HMG-CoA) reductase inhibitors, thiazolidinediones, sodium-glucose cotranspo …
Obesity, Polycystic Ovary Syndrome, and Infertility: A New Avenue for GLP-1 Receptor Agonists.
Cena H, Chiovato L, Nappi RE. Cena H, et al. J Clin Endocrinol Metab. 2020 Aug 1;105(8):e2695-709. doi: 10.1210/clinem/dgaa285. J Clin Endocrinol Metab. 2020. PMID: 32442310 Free PMC article. Review.
EVIDENCE ACQUISITION: The aim of the present narrative review is to describe the mechanisms responsible for the development of infertility and PCOS in women with obesity/overweight, with a focus on the emerging role of glucagon-like peptide-1 (GLP-1) receptor agonists (GLP …
EVIDENCE ACQUISITION: The aim of the present narrative review is to describe the mechanisms responsible for the development of infertility a …
Hirsutism in Women.
Matheson E, Bain J. Matheson E, et al. Am Fam Physician. 2019 Aug 1;100(3):168-175. Am Fam Physician. 2019. PMID: 31361105 Free article. Review.
Less common causes include idiopathic hirsutism, nonclassic congenital adrenal hyperplasia, androgen-secreting tumors, medications, hyperprolactinemia, thyroid disorders, and Cushing syndrome. ...Women with rapid onset of hirsutism over a few months or signs of virilizatio …
Less common causes include idiopathic hirsutism, nonclassic congenital adrenal hyperplasia, androgen-secreting tumors, medications, h …
Tumour immune rejection triggered by activation of alpha2-adrenergic receptors.
Zhu J, Naulaerts S, Boudhan L, Martin M, Gatto L, Van den Eynde BJ. Zhu J, et al. Nature. 2023 Jun;618(7965):607-615. doi: 10.1038/s41586-023-06110-8. Epub 2023 Jun 7. Nature. 2023. PMID: 37286594
Here we show that agonists of alpha2-adrenergic receptors (alpha2-AR) have very strong anti-tumour activity when used as monotherapies in multiple immunocompetent tumour models, including ICB-resistant models, but not in immunodeficient models. ...The anti- …
Here we show that agonists of alpha2-adrenergic receptors (alpha2-AR) have very strong anti-tumour activity when used as monot …
Low-grade developmental and epilepsy associated brain tumors: a critical update 2020.
Slegers RJ, Blumcke I. Slegers RJ, et al. Acta Neuropathol Commun. 2020 Mar 9;8(1):27. doi: 10.1186/s40478-020-00904-x. Acta Neuropathol Commun. 2020. PMID: 32151273 Free PMC article. Review.
Characteristic entities comprise the ganglioglioma (GG), the dysembryoplastic neuroepithelial tumor (DNT), the angiocentric glioma (AG), the isomorphic diffuse glioma (IDG) and the papillary glio-neuronal tumor (PGNT), representing 73.2% of 1680 tumors …
Characteristic entities comprise the ganglioglioma (GG), the dysembryoplastic neuroepithelial tumor (DNT), the angiocentric glioma ( …
Polycystic ovary syndrome: a "risk-enhancing" factor for cardiovascular disease.
Guan C, Zahid S, Minhas AS, Ouyang P, Vaught A, Baker VL, Michos ED. Guan C, et al. Fertil Steril. 2022 May;117(5):924-935. doi: 10.1016/j.fertnstert.2022.03.009. Fertil Steril. 2022. PMID: 35512976 Free article. Review.
Other medications, such as metformin and glucagon-like peptide-1 receptor agonists, also may be useful in reducing CVD risk in insulin-resistant populations. ...
Other medications, such as metformin and glucagon-like peptide-1 receptor agonists, also may be useful in reducing CVD risk in insuli …
The FIGO ovulatory disorders classification system.
Munro MG, Balen AH, Cho S, Critchley HOD, Díaz I, Ferriani R, Henry L, Mocanu E, van der Spuy ZM; FIGO Committee on Menstrual Disorders and Related Health Impacts, and FIGO Committee on Reproductive Medicine, Endocrinology, and Infertility. Munro MG, et al. Int J Gynaecol Obstet. 2022 Oct;159(1):1-20. doi: 10.1002/ijgo.14331. Epub 2022 Aug 19. Int J Gynaecol Obstet. 2022. PMID: 35983674 Free PMC article.
Aryl hydrocarbon receptor ligands in cancer: friend and foe.
Murray IA, Patterson AD, Perdew GH. Murray IA, et al. Nat Rev Cancer. 2014 Dec;14(12):801-14. doi: 10.1038/nrc3846. Nat Rev Cancer. 2014. PMID: 25568920 Free PMC article. Review.
Interestingly, ligand specificity and affinity vary between rodents and humans. Studies of aggressive tumours and tumour cell lines show increased levels of AHR and constitutive localization of this receptor in the nucleus. This suggests that the AHR is chronically …
Interestingly, ligand specificity and affinity vary between rodents and humans. Studies of aggressive tumours and tumour cell …
Activity of Selumetinib in Neurofibromatosis Type 1-Related Plexiform Neurofibromas.
Dombi E, Baldwin A, Marcus LJ, Fisher MJ, Weiss B, Kim A, Whitcomb P, Martin S, Aschbacher-Smith LE, Rizvi TA, Wu J, Ershler R, Wolters P, Therrien J, Glod J, Belasco JB, Schorry E, Brofferio A, Starosta AJ, Gillespie A, Doyle AL, Ratner N, Widemann BC. Dombi E, et al. N Engl J Med. 2016 Dec 29;375(26):2550-2560. doi: 10.1056/NEJMoa1605943. N Engl J Med. 2016. PMID: 28029918 Free PMC article. Clinical Trial.
We also tested selumetinib using a mouse model of neurofibromatosis type 1-related neurofibroma. Response to treatment (i.e., an increase or decrease from baseline in the volume of plexiform neurofibromas) was monitored by using volumetric magnetic resonance imaging …
We also tested selumetinib using a mouse model of neurofibromatosis type 1-related neurofibroma. Response to treatment (i.e., an incr …
65,482 results
You have reached the last available page of results. Please see the User Guide for more information.